By the Templateez Team · Licensed Attorney · June 2026

Pharmacy Intake Forms: What Independent and Compounding Pharmacies Need to Capture at Patient Intake

A pharmacy that fills a prescription without knowing the patient's complete medication list, allergy profile, and renal function status is not just providing poor service — it is creating a dispensing risk that can injure or kill someone. Chain pharmacies push volume and rely on automated DUR systems to catch what their hurried technicians miss. Independent and compounding pharmacies exist because they do more than that. But "more" only works if you actually capture the information that makes clinical judgment possible.

Most pharmacy intake workflows collect a name, date of birth, insurance card, and a single "any allergies?" checkbox. That is a billing intake, not a clinical one. A real pharmacy intake form captures the full patient profile your pharmacists need to dispense safely, bill correctly, and provide the medication therapy management that justifies your value over the mail-order alternative. Here is what that form should include.

Patient demographics: more than a label for the bottle

Demographics drive clinical decisions in pharmacy more directly than in most healthcare settings. Age determines pediatric and geriatric dosing adjustments. Weight matters for narrow therapeutic index drugs. Sex affects drug metabolism, contraindication screening, and pregnancy-related dispensing holds. Your intake should capture:

• Full legal name and preferred name — the legal name matches the insurance and prescriber records. The preferred name goes on counseling notes and consultation calls so the patient feels known, not processed.
• Date of birth and age — pediatric patients under 12 and geriatric patients over 65 both trigger different dosing protocols, different DUR sensitivity thresholds, and different counseling requirements in most states.
• Sex assigned at birth and gender identity — biological sex is pharmacologically relevant for drug metabolism, pregnancy screening, and hormone interaction checks. Gender identity is relevant for respectful communication and for patients on hormone therapy whose medication profile may not match expectations based on legal sex markers.
• Weight — critical for weight-based dosing (antibiotics, anticoagulants, chemotherapy agents) and for compounding calculations. Optional for standard dispensing but should be on the form for when it matters.
• Primary language and interpreter needs — medication counseling in a language the patient does not understand is not counseling. Document the language and whether an interpreter is needed so your pharmacists can prepare or arrange translation resources before the patient arrives.
• Contact information — phone (with preference for calls vs. texts), email, and emergency contact. Pharmacy has a unique need for reliable phone contact because refill reminders, prior authorization updates, and drug recall notifications all depend on reaching the patient quickly.

Current medications: the complete picture, not just what you dispense

Drug interaction screening only works if the screening system knows every drug the patient takes — not just the ones filled at your pharmacy. Patients who use multiple pharmacies, receive samples from their physician, or take OTC products daily create interaction risks that your dispensing software cannot flag if it does not know about those medications.

• All prescription medications — drug name, strength, dosage form, prescriber, and frequency. Include medications filled at other pharmacies. Patients often forget to mention a prescription they get from a specialist at a different pharmacy — the cardiologist's warfarin filled across town is exactly the kind of medication your system needs to know about.
• Over-the-counter medications and supplements — aspirin, ibuprofen, acetaminophen, fish oil, vitamin D, melatonin, herbal supplements (St. John's Wort, ginkgo, turmeric). Patients do not think of these as medications. They are. St. John's Wort induces CYP3A4 and can reduce the efficacy of oral contraceptives, antiretrovirals, and immunosuppressants. Your intake form needs to ask specifically about OTC and supplement use, not just "other medications."
• Medication adherence concerns — does the patient have trouble remembering doses? Difficulty swallowing pills? Cost concerns that lead to pill-splitting or skipped doses? This information drives your counseling approach and may qualify the patient for MTM services or manufacturer assistance programs.

Allergy and adverse reaction history: severity and reaction type matter

A checkbox that says "penicillin allergy" is clinically useless without knowing whether the reaction was anaphylaxis or a mild rash twenty years ago. The difference between those two scenarios determines whether the patient can safely receive cephalosporins, carbapenems, or any beta-lactam. Your allergy documentation needs granularity:

• Drug allergies — the specific drug (not just the class), the reaction experienced (rash, hives, anaphylaxis, angioedema, Stevens-Johnson syndrome, GI distress), severity (mild, moderate, severe, life-threatening), and when it occurred. A patient who had a mild stomach upset on erythromycin twenty years ago has a fundamentally different risk profile than a patient who was intubated after amoxicillin last year.
• Food allergies — relevant because some medications contain food-derived ingredients. Egg allergies affect certain vaccines. Soy allergies affect some formulations. Peanut oil appears in some compounded preparations. Lactose intolerance matters for tablet excipients.
• Latex allergy — affects glove use during compounding and immunization administration, and some medication vial stoppers contain natural rubber latex.
• Dye and preservative sensitivities — tartrazine (FD&C Yellow No. 5), sulfites, parabens, benzalkonium chloride. These appear in tablets, capsules, solutions, and ophthalmic preparations. Patients with these sensitivities may need alternative formulations or compounded preparations without the offending excipient.

This level of allergy documentation connects directly to the broader HIPAA-compliant intake form requirements that govern how you collect, store, and transmit protected health information in a pharmacy setting.

Medical conditions affecting dispensing

Your pharmacists are not diagnosing conditions. They are screening for conditions that change how a drug is metabolized, excreted, or tolerated. Certain medical conditions require dose adjustments, alternative agents, or enhanced monitoring that your dispensing system cannot flag without this information:

• Renal impairment — the single most common reason for pharmacy dose adjustments. Drugs cleared renally (metformin, gabapentin, most antibiotics, lithium, digoxin) require reduced doses or extended intervals in patients with reduced GFR. Ask whether the patient has been diagnosed with kidney disease or told their kidney function is reduced.
• Hepatic impairment — affects metabolism of drugs processed through the liver (statins, benzodiazepines, acetaminophen, most opioids). Patients with cirrhosis, hepatitis, or liver disease may need dose reductions or alternative agents.
• Pregnancy and nursing status — pregnancy category screening is the most basic dispensing safety check, and it fails when the pharmacy does not know the patient is pregnant. Ask directly. Also capture breastfeeding status, since many drugs pass into breast milk at clinically significant levels.
• Diabetes, cardiovascular disease, thyroid disorders — these chronic conditions interact with dozens of drug classes. A patient on metformin who receives a contrast dye procedure needs a temporary hold. A patient on warfarin who starts an antibiotic needs INR monitoring. These interactions are only caught if the conditions are documented.

Insurance and PBM information: the billing infrastructure

Pharmacy billing is more complex than medical billing because it runs through Pharmacy Benefit Managers rather than directly through insurers, and the patient often stands at the counter expecting a price in real time. Rejected claims that could have been prevented with complete intake information waste staff time and frustrate patients. Capture:

• Primary insurance — carrier name, RxBIN, RxPCN, Group number, Member ID, and Person Code. All six fields matter. A claim with a wrong PCN rejects. A claim with a missing Person Code defaults to the primary cardholder when the patient is a dependent, and the claim rejects.
• Secondary insurance — same fields. Patients with Medicare Part D plus a supplemental plan, or Medicaid as secondary, need both plans on file for proper coordination of benefits.
• Workers' compensation or auto insurance — for medications related to workplace injuries or motor vehicle accidents, the billing path is entirely different. Capture the claim number, adjuster contact, and date of injury.
• Prior authorization status — does the patient know whether any of their current medications required a prior authorization? Has the prescriber's office mentioned a pending PA? Knowing this at intake prevents the patient from arriving to pick up a medication that has not been approved and will not be ready.
• Discount card or manufacturer coupon — patients increasingly present GoodRx, SingleCare, or manufacturer copay cards. Document these at intake so your system applies them consistently without the patient needing to re-present the card at every fill.

Prescriber information

Your intake form should capture the patient's primary prescribers so your pharmacists can reach them efficiently when clinical questions arise:

• Primary care physician — name, practice, phone, and fax. Most prescription clarifications and refill authorizations go to the PCP.
• Specialists — cardiologist, endocrinologist, psychiatrist, oncologist, or any specialist who writes prescriptions for the patient. When a drug interaction question involves a specialist's prescription, your pharmacist needs to reach that specialist directly, not route through the PCP and wait two days.
• Preferred prescriber for OTC recommendations — when your pharmacist recommends an OTC product that may interact with a prescription, who should be notified? This is especially relevant for geriatric patients on complex regimens.

Medication therapy management eligibility

MTM is both a clinical service and a revenue stream for independent pharmacies. CMS-eligible patients and patients whose Part D plans include MTM benefits represent billable consultation opportunities that most pharmacies miss because they never screen for eligibility at intake. Your form should capture:

• Number of chronic conditions — patients with multiple chronic conditions (typically three or more) are more likely to meet MTM eligibility thresholds.
• Number of Part D covered medications — the CMS threshold varies by year but typically requires eight or more Part D medications.
• Annual drug cost threshold — estimated annual medication spend. CMS sets a dollar threshold for MTM eligibility that changes each plan year.
• Interest in comprehensive medication review — even patients who do not meet automatic eligibility may benefit from and be willing to pay for a comprehensive medication review. Asking at intake surfaces this opportunity.

Immunization history and screening

Pharmacies are now a primary immunization access point. Your intake form should support vaccine screening and documentation. Much of this overlaps with the general clinical intake that optometry practices and other healthcare providers capture — the difference is that pharmacy specifically needs immunization-focused history:

• Immunization history — flu (last date), COVID-19 (dates and manufacturer for each dose), pneumococcal (PCV20 or PPSV23 + PCV15 series status), shingles (Shingrix dose 1 and 2 dates), Tdap/Td (last date), hepatitis B series status.
• Screening questions — current illness or fever, immunocompromised status, pregnancy, previous severe reaction to a vaccine or vaccine component, history of Guillain-Barré syndrome.
• State registry consent — most states maintain immunization information systems (IIS) and require or allow pharmacies to report administered vaccines. Your intake should include consent for IIS reporting where required.

Controlled substance risk factors and PDMP consent

Every state now operates a Prescription Drug Monitoring Program, and most require pharmacists to check it before dispensing Schedule II through IV controlled substances. Your intake should support this workflow:

• PDMP check consent — inform the patient that you are required to check the state PDMP before dispensing controlled substances and obtain acknowledgment. This is both a legal requirement and a clinical safeguard.
• Current controlled substance prescriptions — ask specifically whether the patient currently receives opioids, benzodiazepines, stimulants, or other controlled substances from any prescriber. Patients who disclose this voluntarily at intake reduce the friction of PDMP-driven conversations later.
• Pain management agreement status — is the patient under a pain management contract with a specific prescriber? These contracts often designate a single pharmacy. Knowing this at intake prevents your pharmacy from inadvertently filling a prescription that violates the patient's pain management agreement.

Compounding needs: the independent pharmacy differentiator

Compounding is where independent pharmacies earn margins that PBM reimbursement rates on commercial products cannot match. But compounding requires intake information that standard dispensing does not:

• Allergen-free formulation requirements — patients who need dye-free, gluten-free, lactose-free, casein-free, or preservative-free preparations. Document the specific allergen so your compounding pharmacist can select appropriate bases, suspending agents, and flavoring systems.
• Dosage form preferences — patients who cannot swallow capsules may need liquids, troches, transdermal creams, or suppositories. Pediatric patients often need flavored suspensions. Hospice patients may need concentrated sublingual formulations. Capture the preference and the clinical reason so your pharmacist can recommend the most appropriate form.
• Flavoring preferences — particularly for pediatric compounding. A child who will not take a grape-flavored suspension but will take bubblegum is the difference between medication adherence and a parent calling back in frustration three days later.
• Current compounding prescriptions — is the patient already receiving compounded medications from another pharmacy? What formulations? What bases? This prevents duplication and identifies formulation preferences that already work for the patient.

Medication synchronization

Med sync programs align all of a patient's refills to a single pickup date each month. This improves adherence, reduces pharmacy workload over time, and creates a predictable recurring revenue pattern. Your intake should assess eligibility:

• Number of chronic medications — patients on three or more chronic medications are the best candidates for med sync.
• Current refill patterns — are refills scattered across the month? Does the patient frequently run out early or pick up late? These are signs that synchronization would help.
• Interest in enrollment — explain the program briefly on the form and ask whether the patient would like to participate. Many patients do not know this service exists until you offer it.
• Preferred pickup date — align with the patient's schedule — the first of the month, the 15th, the day after they receive their Social Security deposit. The pickup date should be convenient enough that the patient actually shows up consistently.

HIPAA authorization and caregiver access

Pharmacy handles HIPAA differently than most healthcare settings because prescription information is disclosed at the point of pickup, often to someone other than the patient. Your intake needs to capture:

• HIPAA acknowledgment — the patient's acknowledgment that they have received your Notice of Privacy Practices. This is a federal requirement, and the date of acknowledgment must be documented.
• Authorized pickup persons — name and relationship of anyone authorized to pick up prescriptions on the patient's behalf. A spouse, adult child, caregiver, home health aide. Without documented authorization, your staff faces a HIPAA judgment call every time someone other than the patient shows up at the counter.
• Caregiver medication management authorization — for elderly or disabled patients whose medications are managed by a caregiver, document whether the caregiver is authorized to discuss the patient's medications, request refills, receive counseling on the patient's behalf, and make formulary decisions when the prescriber offers alternatives.
• Communication preferences — can you leave a voicemail that mentions medication names? Can you send text refill reminders? Can you discuss prescriptions with family members who call? Each of these is a HIPAA disclosure decision that should be documented at intake, not improvised at the counter.

Building a pharmacy practice, not just a dispensing operation

The difference between an independent pharmacy that thrives and one that slowly loses patients to mail-order is the clinical relationship. A thorough intake form is the foundation of that relationship. When a new patient fills out a form that asks about their renal function, their compounding preferences, and their med sync interest, they understand immediately that this pharmacy operates at a different level than the chain where nobody knows their name and the pharmacist has ninety seconds per consultation.

That intake form is also your defense in a dispensing error claim, your documentation for MTM billing, your evidence of PDMP compliance, and your record of the clinical judgment your pharmacists exercise every day. It is not paperwork — it is the infrastructure of a practice.

If you are building documentation across a healthcare operation, the Healthcare Bundle includes pharmacy alongside 20 other healthcare categories, each with profession-specific intake fields designed for clinical environments.